Helix BioMedix, Inc. (HXBM)

Market Cap	1.45M
Revenue (ttm)	2.07M
Net Income (ttm)	-2.58M
Shares Out	224.71K
EPS (ttm)	-15.59
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	142
Average Volume	235
Open	6.45
Previous Close	n/a
Day's Range	6.45 - 6.45
52-Week Range	6.45 - 23.50
Beta	0.60
RSI	19.22
Earnings Date	n/a

About Helix BioMedix

Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 8
• Stock Exchange: OTCMKTS
• Ticker Symbol: HXBM

Financial Performance

In 2011, Helix BioMedix's revenue was $1.89 million, an increase of 122.07% compared to the previous year's $851,683. Losses were -$2.49 million, -67.73% less than in 2010.